157 related articles for article (PubMed ID: 1001205)
1. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
Vogelberg KH
Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
[TBL] [Abstract][Full Text] [Related]
3. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
Vogelberg KH; Althoff B; Heggen EM; Thesseling W
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():832-5. PubMed ID: 196437
[No Abstract] [Full Text] [Related]
4. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Gaertner U; Johannes KJ
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
[TBL] [Abstract][Full Text] [Related]
7. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
Jung W; Kremer GJ; Müller D
MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
Wilke H; Frahm H
Dtsch Med Wochenschr; 1976 Mar; 101(11):401-5. PubMed ID: 1253701
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
10. [Biguanide therapy of primary hyperlipoproteinemias type IIb, 3 and IV as monotherapy and combined with clofibrate].
Koschinsky T; Vogelberg KH; Gries FA
Verh Dtsch Ges Inn Med; 1973; 79():1294-6. PubMed ID: 4795174
[No Abstract] [Full Text] [Related]
11. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
Vogelberg KH; Cicmir I; Heggen ME
Arzneimittelforschung; 1980; 30(4):683-5. PubMed ID: 7190412
[TBL] [Abstract][Full Text] [Related]
12. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
Kaffarnik H; Schneider J; Haase W
Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
Mertz DP; Suermann J
Med Klin; 1978 Jun; 73(23):867-73. PubMed ID: 207959
[TBL] [Abstract][Full Text] [Related]
14. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)].
Lang PD; Vollmar J; Klemens UH; von Löwis P; Gries FA; Koschinsky T; Huth K; Pilz E; Schlierf G; Kremer GJ; Lenhart P; Schwandt P; Hammerl H; Studlar M
Dtsch Med Wochenschr; 1973 Nov; 98(48):2280-6. PubMed ID: 4762828
[No Abstract] [Full Text] [Related]
15. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
Wolfram G; Keller C; Kilani S; Zöllner N
Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
[TBL] [Abstract][Full Text] [Related]
16. [Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
Wahl P; Hasslacher C; Lang PD; Vollmar J
Dtsch Med Wochenschr; 1978 Aug; 103(31):1233-7. PubMed ID: 668570
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyperlipoproteinemias (author's transl)].
Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
[No Abstract] [Full Text] [Related]
18. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
Dunnigan MG; Cochrane MA; Kelly A; Scott JW
Q J Med; 1974 Jan; 43(169):33-48. PubMed ID: 4362786
[No Abstract] [Full Text] [Related]
19. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
Hammerl H; Nebosis G; Pichler O; Studlar M
Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881
[No Abstract] [Full Text] [Related]
20. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
